Molbio Diagnostics IPO was subscribed over 70 times by the end of the 3-day bidding period on Wednesday for its Rs 939 crore issue. The over-subscription was led by Qualified Institutional Buyers, who bid over 180 times their allotted portion.
The point-of-care molecular diagnostics company is also commanding a 17.10% grey market premium (GMP), up from 15% earlier, indicating expectations of a potentially strong listing.